WARF Therapeutics

Invest-Develop-Partner

Found in Translation:
New directions in drug discovery at UW–Madison

Thursday, February 21, 2019

Discovery Building | H.F. DeLuca Forum | 330 N. Orchard St., Madison

Learn about new opportunities for moving solutions from the lab to the patient. The event will be held from 9 a.m. to noon and feature:

Allan Brasier (9-9:30 a.m.)

Senior Associate Dean of the School of Medicine and Public Health, and Executive Director of the Institute for Clinical and Translational Research (ICTR)

Jon Young (9:30-10:30 a.m.)

Head of WARF Therapeutics - a new initiative to advance pharmaceuticals closer to patients


free_breakfast

10:30-11 a.m. networking/coffee break


Plus a panel of campus experts with deep pharma development experience. (11 a.m. -Noon)


Jennifer Golden

Assistant professor in the School of Pharmacy and associate director of the Medicinal Chemistry Center. Golden's lab develops novel synthetic methodologies for designing small molecule therapeutics.

Doug McNeel

Professor in the School of Medicine and Public Health and scientific founder and chief medical officer of Madison Vaccines Inc. MVI is a clinical stage biopharma company developing gene-based immunotherapies for prostate cancer.

Luigi Puglielli

Professor in the School of Medicine and Public Health. Dr. Puglielli's research focuses broadly on molecular mechanisms of neurodevelopment and neurodegeneration.